840875 | 18:1 PA
1,2-dioleoyl-sn-glycero-3-phosphate (sodium salt)
18:1 PA
1,2-dioleoyl-sn-glycero-3-phosphate (sodium salt)
CAS Registry Number is a Registered Trademark of the American Chemical Society
DOPA
PA(18:1(9Z)/18:1(9Z))
Yamada H, Hoshino F, Lu Q, Sakane F. Cellular phosphatidic acid sensor, α-synuclein N-terminal domain, detects endogenous phosphatidic acid in macrophagic phagosomes and neuronal growth cones. Biochem Biophys Rep. 2020 May 20;22:100769. doi: 10.1016/j.bbrep.2020.100769. PMID: 32490215; PMCID: PMC7261706.
PubMed ID: 32490215Rudolphi-Szydło E, Filek M, Dyba B, Miszalski Z, Zembala M. Antioxidative action of polyamines in protection of phospholipid membranes exposed to ozone stress. Acta Biochim Pol. 2020 May 21;67(2):259-262. doi: 10.18388/abp.2020_5230. PMID: 32436672.
PubMed ID: 32436672Hu Z, Nizzero S, Goel S, Hinkle LE, Wu X, Li C, Ferrari M, Shen H. Molecular targeting of FATP4 transporter for oral delivery of therapeutic peptide. Sci Adv. 2020 Apr 1;6(14):eaba0145. doi: 10.1126/sciadv.aba0145. PMID: 32270048; PMCID: PMC7112756.
PubMed ID: 32270048Han X, Yang Y, Zhao F, Zhang T, Yu X. An improved protein lipid overlay assay for studying lipid-protein interactions. Plant Methods. 2020 Mar 6;16:33. doi: 10.1186/s13007-020-00578-5. PMID: 32165912; PMCID: PMC7060618.
PubMed ID: 32165912Hong AW, Meng Z, Plouffe SW, Lin Z, Zhang M, Guan KL. Critical roles of phosphoinositides and NF2 in Hippo pathway regulation. Genes Dev. 2020 Apr 1;34(7-8):511-525. doi: 10.1101/gad.333435.119. Epub 2020 Feb 27. PMID: 32115406; PMCID: PMC7111263.
PubMed ID: 32115406Peppino Margutti M, Wilke N, Villasuso AL. Influence of Ca2+ on the surface behavior of phosphatidic acid and its mixture with diacylglycerol pyrophosphate at different pHs. Chem Phys Lipids. 2020 May;228:104887. doi: 10.1016/j.chemphyslip.2020.104887. Epub 2020 Feb 3. PMID: 32027867.
PubMed ID: 32027867Huang Y, Chen Y, Zhou S, Chen L, Wang J, Pei Y, Xu M, Feng J, Jiang T, Liang K, Liu S, Song Q, Jiang G, Gu X, Zhang Q, Gao X, Chen J. Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors. Nat Commun. 2020 Jan 30;11(1):622. doi: 10.1038/s41467-020-14425-7. PMID: 32001695; PMCID: PMC6992734.
PubMed ID: 32001695Zhu H, Liu Q, Miao L, Musetti S, Huo M, Huang L. Remodeling the fibrotic tumor microenvironment of desmoplastic melanoma to facilitate vaccine immunotherapy. Nanoscale. 2020 Feb 7;12(5):3400-3410. doi: 10.1039/c9nr09610h. Epub 2020 Jan 28. PMID: 31989142.
PubMed ID: 31989142Huang KW, Hsu FF, Qiu JT, Chern GJ, Lee YA, Chang CC, Huang YT, Sung YC, Chiang CC, Huang RL, Lin CC, Dinh TK, Huang HC, Shih YC, Alson D, Lin CY, Lin YC, Chang PC, Lin SY, Chen Y. Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. Sci Adv. 2020 Jan 15;6(3):eaax5032. doi: 10.1126/sciadv.aax5032. PMID: 31998834; PMCID: PMC6962042.
PubMed ID: 31998834Gusti-Ngurah-Putu EP, Huang L, Hsu YC. Effective Combined Photodynamic Therapy with Lipid Platinum Chloride Nanoparticles Therapies of Oral Squamous Carcinoma Tumor Inhibition. J Clin Med. 2019 Dec 2;8(12):2112. doi: 10.3390/jcm8122112. PMID: 31810241; PMCID: PMC6947167.
PubMed ID: 31810241Huang Y, Xiao Z, Guan Z, Shen Y, Jiang Y, Xu X, Huang Z, Zhao C. A light-triggered self-reinforced nanoagent for targeted chemo-photodynamic therapy of breast cancer bone metastases via ER stress and mitochondria mediated apoptotic pathways. J Control Release. 2019 Dec 25;319:119-134. doi: 10.1016/j.jconrel.2019.12.043. [Epub ahead of print]. PMID: 31883459.
PubMed ID: 31883459Cao Z, Wang X, Pang Y, Cheng S, Liu J. Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment. Nat Commun. 2019 Dec 19;10(1):5783. doi: 10.1038/s41467-019-13727-9.
PubMed ID: 31857577Fantin SM, Parson KF, Niu S, Liu J, Polasky DA, Dixit SM, Ferguson-Miller SM, Ruotolo BT. Collision Induced Unfolding Classifies Ligands Bound to the Integral Membrane Translocator Protein. Anal Chem. 2019 Dec 17;91(24):15469-15476. doi: 10.1021/acs.analchem.9b03208. Epub 2019 Dec 5.
PubMed ID: 31743004Zhang R, Qiao C, Jia Q, Wang Y, Huang H, Chang W, Wang H, Zhang H, Wang Z. Highly Stable and Long-Circulating Metal-Organic Frameworks Nanoprobes for Sensitive Tumor Detection In Vivo. Adv Healthc Mater. 2019 Jul 31:e1900761. doi: 10.1002/adhm.201900761. [Epub ahead of print]
PubMed ID: 31368240An Y, Zhu J, Liu F, Deng J, Meng X, Liu G, Wu H, Fan A, Wang Z, Zhao Y. Boosting the Ferroptotic Antitumor Efficacy via Site-Specific Amplification of Tailored Lipid Peroxidation. ACS Appl Mater Interfaces. 2019 Aug 21;11(33):29655-29666. doi: 10.1021/acsami.9b10954. Epub 2019 Aug 8.
PubMed ID: 31359759Yanjuan Huang, Yali Jiang, Zhanghong Xiao, Yifeng Shen, Liangfeng Huang, Xiaoyu Xu, Gaofei Wei, Congjun Xu, Chunshun Zhao. Three birds with one stone: A ferric pyrophosphate based nanoagent for synergetic NIR-triggered photo/chemodynamic therapy with glutathione depletion. Chemical Engineering Journal. 15 January 2020;380:122369. doi: 10.1016/j.cej.2019.1222369
Khan MW, Zhao P, Khan A, Raza F, Raza SM, Sarfraz M, Chen Y, Li M, Yang T, Ma X, Xiang G. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity. Int J Nanomedicine. 2019 May 28;14:3753-3771. doi: 10.2147/IJN.S196651. eCollection 2019.
PubMed ID: 31239661Tang J, Li B, Howard CB, Mahler SM, Thurecht KJ, Wu Y, Huang L, Xu ZP. Multifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy. Biomaterials. 2019 May 31;216:119232. doi: 10.1016/j.biomaterials.2019.119232. [Epub ahead of print]
PubMed ID: 31195300Kulig W, Korolainen H, Zatorska M, Kwolek U, Wydro P, Kepczynski M, Róg T. Complex Behavior of Phosphatidylcholine-Phosphatidic Acid Bilayers and Monolayers: Effect of Acyl Chain Unsaturation. Langmuir. 2019 Apr 30;35(17):5944-5956. doi: 10.1021/acs.langmuir.9b00381. Epub 2019 Apr 16.
PubMed ID: 30942590Zang X, Zhang X, Hu H, Qiao M, Zhao X, Deng Y, Chen D. Targeted Delivery of Zoledronate to Tumor-Associated Macrophages for Cancer Immunotherapy. Mol Pharm. 2019 May 6;16(5):2249-2258. doi: 10.1021/acs.molpharmaceut.9b00261. Epub 2019 Apr 22.
PubMed ID: 30969779Duan X, Chan C, Han W, Guo N, Weichselbaum RR, Lin W. Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors. Nat Commun. 2019 Apr 23;10(1):1899. doi: 10.1038/s41467-019-09221-x.
PubMed ID: 31015397Wu Y, Gu W, Li J, Chen C, Xu ZP. Silencing PD-1 and PD-L1 with nanoparticle-delivered small interfering RNA increases cytotoxicity of tumor-infiltrating lymphocytes. Nanomedicine (Lond). 2019 Apr;14(8):955-967. doi: 10.2217/nnm-2018-0237. Epub 2019 Mar 22.
PubMed ID: 3091292Kulig W, Korolainen H, Zatorska M, Kwolek U, Wydro P, Kepczynski M, Róg T. Complex Behavior of Phosphatidylcholine-Phosphatidic Acid Bilayers and Monolayers: Effect of Acyl Chain Unsaturation. Langmuir. 2019 Apr 16. doi: 10.1021/acs.langmuir.9b00381. [Epub ahead of print]
PubMed ID: 30942590Gao S, Wan Y, Li W, Huang C. Visualized Networking of Co-Regulated Lipids in Human Blood Based on High-Throughput Screening Data: Implications for Exposure Assessment. Environ Sci Technol. 2019 Mar 5;53(5):2862-2872. doi: 10.1021/acs.est.8b06289. Epub 2019 Feb 21.
PubMed ID: 30739451Zhang Y, Bush X, Yan B, Chen JA. Gemcitabine nanoparticles promote antitumor immunity against melanoma. Biomaterials. 2019 Jan;189:48-59. doi: 10.1016/j.biomaterials.2018.10.022. Epub 2018 Oct 20.
PubMed ID: 30388589Amdursky N, Lin Y, Aho N, Groenhof G. Exploring fast proton transfer events associated with lateral proton diffusion on the surface of membranes. Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2443-2451. doi: 10.1073/pnas.1812351116. Epub 2019 Jan 24.
PubMed ID: 30679274Woo J, Jeon YK, Zhang YH, Nam JH, Shin DH, Kim SJ. Am J Physiol Cell Physiol. 2019 Mar 1;316(3):C312-C324. doi: 10.1152/ajpcell.00417.2018. Epub 2018 Dec 21. Triple arginine residues in the proximal C-terminus of TREK K+ channels are critical for biphasic regulation by phosphatidylinositol 4,5-bisphosphate.
PubMed ID: 30576235McCulloch KM, Yamakawa I, Shifrin DA Jr, McConnell RE, Foegeding NJ, Singh PK, Mao S, Tyska MJ, Iverson TM. An alternative N-terminal fold of the intestine-specific annexin A13a induces dimerization and regulates membrane-binding. J Biol Chem. 2019 Mar 8;294(10):3454-3463. doi: 10.1074/jbc.RA118.004571. Epub 2019 Jan 4.
PubMed ID: 30610115Hennessy M, Granade ME, Hassaninasab A, Wang D, Kwiatek JM, Han GS, Harris TE, Carman GM. Casein kinase II-mediated phosphorylation of lipin 1β phosphatidate phosphatase at Ser-285 and Ser-287 regulates its interaction with 14-3-3β protein. J Biol Chem. 2019 Feb 15;294(7):2365-2374. doi: 10.1074/jbc.RA118.007246. Epub 2019 Jan 7.
PubMed ID: 30617183Hennessy M, Granade ME, Hassaninasab A, Wang D, Kwiatek JM, Han GS, Harris TE, Carman GM. Casein kinase II-mediated phosphorylation of lipin 1β phosphatidate phosphatase at Ser-285 and Ser-287 regulates its interaction with 14-3-3β protein. J Biol Chem. 2019 Feb 15;294(7):2365-2374. doi: 10.1074/jbc.RA118.007246. Epub 2019 Jan 7.
PubMed ID: 30617183Binte Mustafiz SS, Uyama T, Hussain Z, Kawai K, Tsuboi K, Araki N, Ueda N. The role of intracellular anionic phospholipids in the production of N-acyl-phosphatidylethanolamines by cytosolic phospholipase A2ε. J Biochem. 2018 Dec 4. doi: 10.1093/jb/mvy104. [Epub ahead of print]
PubMed ID: 30517655Mizuno H, Kihara Y, Kussrow A, Chen A, Ray M, Rivera R, Bornhop DJ, Chun J. Lysophospholipid G protein-coupled receptor binding parameters as determined by backscattering interferometry. J Lipid Res. 2019 Jan;60(1):212-217. doi: 10.1194/jlr.D089938. Epub 2018 Nov 21.
PubMed ID: 30463988Gao S, Wan Y, Li W, Huang C. Visualized Networking of Co-Regulated Lipids in Human Blood Based on High-Throughput Screening Data: Implications for Exposure Assessment. Environ Sci Technol. 2019 Feb 21. doi: 10.1021/acs.est.8b06289. [Epub ahead of print
PubMed ID: 30739451Das M, Shen L, Liu Q, Goodwin TJ, Huang L. Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer. Mol Ther. 2018 Nov 17. pii: S1525-0016(18)30548-3. doi: 10.1016/j.ymthe.2018.11.012. [Epub ahead of print].
PubMed ID: 30545600Thomas LL, van der Vegt SA, Fromme JC. A Steric Gating Mechanism Dictates the Substrate Specificity of a Rab-GEF. Dev Cell. 2019 Jan 7;48(1):100-114.e9. doi: 10.1016/j.devcel.2018.11.013. Epub 2018 Dec 6.
PubMed ID: 30528786Feng Y, Chen B, Yu Q, Li L. Identification of Double Bond Position Isomers in Unsaturated Lipids by m-CPBA Epoxidation and Mass Spectrometry Fragmentation. Anal Chem. 2019 Jan 4. doi: 10.1021/acs.analchem.8b04905. [Epub ahead of print]
PubMed ID: 30608661Chung PJ, Hwang HL, Dasbiswas K, Leong A, Lee KYC. Osmotic shock-triggered assembly of highly-charged, nanoparticle-supported membranes. Langmuir. 2018 Oct 10. doi: 10.1021/acs.langmuir.8b03026. [Epub ahead of print]
PubMed ID: 30303390Ma L, Li Y, Ma J, Hu S, Li M. Watching Three-Dimensional Movements of Single Membrane Proteins in Lipid Bilayers. Biochemistry. 2018 Apr 12. doi: 10.1021/acs.biochem.8b00253
PubMed ID: 29619828- Certificate of Analysis (Lot No. 840875C-1G-A-137 and 5568CQA137)
- Certificate of Analysis (Lot No. 840875C-200MG-A-137 and 5568CNA137)
- Certificate of Analysis (Lot No. 840875C-25MG-A-135 and 5568CJA135)
- Certificate of Analysis (Lot No. 840875C-500MG-A-137 and 5568CPA137)
- Certificate of Analysis (Lot No. 840875P-1G-A-137 and 5568PQA137)
- Certificate of Analysis (Lot No. 840875P-200MG-A-137 and 5568PNA137)
- Certificate of Analysis (Lot No. 840875P-25MG-A-135 and 5568PJA135)
- Certificate of Analysis (Lot No. 840875P-500MG-A-137 and 5568PPA137)
- Certificate of Analysis (Lot No. 840875C-1G-B-137 and 5568CQB137)
- Certificate of Analysis (Lot No. 840875C-25MG-A-137 and 5568CJA137)
- Certificate of Analysis (Lot No. 840875P-200MG-B-137 and 5568PNB137)
- Certificate of Analysis (Lot No. 840875P-25MG-A-137 and 5568PJA137)
- Certificate of Analysis (Lot No. 840875P-200MG-C-137 and 5568PNC137)
- Certificate of Analysis (Lot No. 840875P-1G-A-138 and 5568PQA138)
- Certificate of Analysis (Lot No. 840875C-1G-C-137 and 5568CQC137)
- Certificate of Analysis (Lot No. 840875P-25MG-B-137 and 5568PJB137)
- Certificate of Analysis (Lot No. 840875P-25MG-A-138 and 5568PJA138)
- Certificate of Analysis (Lot No. 840875P-500MG-A-139 and 5568PPA139)
- Certificate of Analysis (Lot No. 840875P-1G-A-139 and 5568PQA139)
- Certificate of Analysis (Lot No. 840875P-200MG-A-139 and 5568PNA139)
- Certificate of Analysis (Lot No. 840875C-25MG-A-139 and 5568CJA139)
- Certificate of Analysis (Lot No. 840875P-25MG-A-139 and 5568PJA139)
- Certificate of Analysis (Lot No. 840875P-25G-A-139 and 5568PXA139)
- Certificate of Analysis (Lot No. 840875C-200MG-A-139 and 5568CNA139)
- Certificate of Analysis (Lot No. 840875C-25MG-B-139 and 5568CJB139)
- Certificate of Analysis (Lot No. 840875C-500MG-A-139 and 5568CPA139)
- Certificate of Analysis (Lot No. 840875P-25MG-A-143 and 5568PJA143)
- Certificate of Analysis (Lot No. 840875P-1G-A-143 and 5568PQA143)
- Certificate of Analysis (Lot No. 840875P-1G-B-143 and 5568PQB143)
- Certificate of Analysis (Lot No. 840875P-CONF-A-144 and 5568PWA144)
- Certificate of Analysis (Lot No. 840875P-1G-C-143 and 5568PQC143)
- Certificate of Analysis (Lot No. 840875P-CONF-B-146 and 5568PWB146)
- Certificate of Analysis (Lot No. 840875P-CONF-A-146 and 5568PWA146)
- Certificate of Analysis (Lot No. 840875P-CONF-A-145 and 5568PWA145)
- Certificate of Analysis (Lot No. 840875C-200MG-A-144 and 5568CNA144)
- Certificate of Analysis (Lot No. 840875P-500MG-A-144 and 5568PPA144)
- Certificate of Analysis (Lot No. 840875P-200MG-A-145 and 5568PNA145)
- Certificate of Analysis (Lot No. 840875P-25MG-A-145 and 5568PJA145)
- Certificate of Analysis (Lot No. 840875P-1G-A-145 and 5568PQA145)
- Certificate of Analysis (Lot No. 840875C-500MG-A-145 and 5568CPA145)
- Certificate of Analysis (Lot No. 840875C-200MG-A-145 and 5568CNA145)
- Certificate of Analysis (Lot No. 840875C-25MG-C-145 and 5568CJC145)
- Certificate of Analysis (Lot No. 840875C-25MG-B-145 and 5568CJB145)
- Certificate of Analysis (Lot No. 840875C-25MG-A-145 and 5568CJA145)
- Certificate of Analysis (Lot No. 840875P-25MG-B-146 and 5568PJB146)
- Certificate of Analysis (Lot No. 840875P-1G-A-146 and 5568PQA146)
- Certificate of Analysis (Lot No. 840875P-25MG-A-145 and 5568PJA145)
- Certificate of Analysis (Lot No. 840875P-1G-A-145 and 5568PQA145)
- Certificate of Analysis (Lot No. 840875P-200MG-A-146 and 5568PNA146)
- Certificate of Analysis (Lot No. 840875C-25MG-A-146 and 5568CJA146)
- Certificate of Analysis (Lot No. 840875P-25MG-A-147 and 5568PJA147)
- Certificate of Analysis (Lot No. 840875P-500MG-A-147 and 5568PPA147)
- Certificate of Analysis (Lot No. 840875C-200MG-A-147 and 5568CNA147)
- Certificate of Analysis (Lot No. 840875P-1G-A-147 and 5568PQA147)
- Certificate of Analysis (Lot No. 840875P-200MG-A-147 and 5568PNA147)
- Certificate of Analysis (Lot No. 840875P-25MG-B-147 and 5568PJB147)
- Certificate of Analysis (Lot No. 840875C-500MG-A-147 and 5568CPA147)
- Certificate of Analysis (Lot No. 840875P-1G-B-147 and 5568PQB147)
- Certificate of Analysis (Lot No. 840875P-500MG-A-148 and 5568PPA148)
- Certificate of Analysis (Lot No. 840875P-200MG-A-148 and 5568PNA148)
- Certificate of Analysis (Lot No. 840875C-25MG-B-148 and 5568CJB148)
- Certificate of Analysis (Lot No. 840875P-25MG-B-148 and 5568PJB148)
- Certificate of Analysis (Lot No. 840875P-25MG-A-148 and 5568PJA148)
- Certificate of Analysis (Lot No. 840875P-1G-A-148 and 5568PQA148)
- Certificate of Analysis (Lot No. 840875C-200MG-A-148 and 5568CNA148)
- Certificate of Analysis (Lot No. 840875C-200MG-B-147 and 5568CNB147)
- Certificate of Analysis (Lot No. 840875P-500MG-B-150 and 5568PPB150)
- Certificate of Analysis (Lot No. 840875P-500MG-A-150 and 5568PPA150)
- Certificate of Analysis (Lot No. 840875P-200MG-D-137 and 5568PND137)
- Certificate of Analysis (Lot No. 840875P-25MG-B-151 and 5568PJB151)
- Certificate of Analysis (Lot No. 840875C-25MG-A-151 and 5568CJA151)
- Certificate of Analysis (Lot No. 840875P-500MG-B-151 and 5568PPB151)
- Certificate of Analysis (Lot No. 840875P-500MG-C-151 and 5568PPC151)
- Certificate of Analysis (Lot No. 840875P-200MG-B-151 and 5568PNB151)
- Certificate of Analysis (Lot No. 840875P-25MG-C-151 and 5568PJC151)
- Certificate of Analysis (Lot No. 840875P-1G-B-151 and 5568PQB151)
- Certificate of Analysis (Lot No. 840875C-500MG-A-151 and 5568CPA151)
- Certificate of Analysis (Lot No. 840875C-200MG-B-151 and 5568CNB151)
- Certificate of Analysis (Lot No. 840875C-25MG-B-151 and 5568CJB151)
- Certificate of Analysis (Lot No. 840875P-25MG-D-151 and 5568PJD151)
- Certificate of Analysis (Lot No. 840875P-1G-C-151 and 5568PQC151)
- Certificate of Analysis (Lot No. 840875C-25MG-C-151 and 5568CJC151)
- Certificate of Analysis (Lot No. 840875C-200MG-C-151 and 5568CNC151)
- Certificate of Analysis (Lot No. 840875P-200MG-A-152 and 5568PNA152)
- Certificate of Analysis (Lot No. 840875P-25MG-A-152 and 5568PJA152)
- Certificate of Analysis (Lot No. 840875P-CONF-E-152 and 5568PWE152)
- Certificate of Analysis (Lot No. 840875P-500MG-D-152 and 5568PPD152)
- Certificate of Analysis (Lot No. 840875P-500MG-C-152 and 5568PPC152)
- Certificate of Analysis (Lot No. 840875P-200MG-C-152 and 5568PNC152)
- Certificate of Analysis (Lot No. 840875P-500MG-C-152 and 5568PPC152)
- Certificate of Analysis (Lot No. 840875P-1G-A-152 and 5568PQA152)
- Certificate of Analysis (Lot No. 840875P-500MG-A-152 and 5568PPA152)
- Certificate of Analysis (Lot No. 840875P-CONF-A-153 and 5568PWA153)
- Certificate of Analysis (Lot No. 840875P-CONF-C-152 and 5568PWC152)
- Certificate of Analysis (Lot No. 840875P-CONF-D-152 and 5568PWD152)
- Certificate of Analysis (Lot No. 840875P-1G-B-152 and 5568PQB152)
- Certificate of Analysis (Lot No. 840875P-25MG-B-152 and 5568PJB152)
- Certificate of Analysis (Lot No. 840875P-200MG-B-152 and 5568PNB152)
- Certificate of Analysis (Lot No. 840875P-500MG-B-152 and 5568PPB152)
- Certificate of Analysis (Lot No. 840875C-25MG-B-152 and 5568CJB152)
- Certificate of Analysis (Lot No. 840875P-25MG-C-152 and 5568PJC152)
- Certificate of Analysis (Lot No. 840875P-200MG-D-152 and 5568PND152)